This page shows the publications co-authored by Daniel Dillon and Christian Webb.
Dissecting the impact of depression on decision-making. Psychol Med. 2020 07; 50(10):1613-1622.
Personalized prediction of antidepressant v. placebo response: evidence from the EMBARC study. Psychol Med. 2019 05; 49(7):1118-1127.
Neural Correlates of Three Promising Endophenotypes of Depression: Evidence from the EMBARC Study. Neuropsychopharmacology. 2016 Jan; 41(2):454-63.
Pretreatment Rostral Anterior Cingulate Cortex Connectivity With Salience Network Predicts Depression Recovery: Findings From the EMBARC Randomized Clinical Trial. Biol Psychiatry. 2019 05 15; 85(10):872-880.
Anxiety and anhedonia in depression: Associations with neuroticism and cognitive control. J Affect Disord. 2019 02 15; 245:1070-1078.
A Novel Strategy to Identify Placebo Responders: Prediction Index of Clinical and Biological Markers in the EMBARC Trial. Psychother Psychosom. 2018; 87(5):285-295.
Pretreatment Rostral Anterior Cingulate Cortex Theta Activity in Relation to Symptom Improvement in Depression: A Randomized Clinical Trial. JAMA Psychiatry. 2018 06 01; 75(6):547-554.
Characterizing anxiety subtypes and the relationship to behavioral phenotyping in major depression: Results from the EMBARC study. J Psychiatr Res. 2018 07; 102:207-215.
Demonstrating test-retest reliability of electrophysiological measures for healthy adults in a multisite study of biomarkers of antidepressant treatment response. Psychophysiology. 2017 01; 54(1):34-50.
The connection strength for co-authors is the sum of the scores for each of their shared publications.
Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.